Hepion Pharmaceuticals's total assets for Q1 2025 were $6.32M, an increase of 291.55% from the previous quarter. HEPA total liabilities were $2.42M for the fiscal quarter, a -30.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.